Oelschlager Kristen M, COO, reported an open-market or private sale at CASTLE BIOSCIENCES INC involving 3952.000000 shares for an estimated $131838.72. Reported holdings after the transaction were 13556.000000 shares. The stored filing text includes a detected 10b5-1 reference.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
Form 4 relationship flags and nearby filing context
Chief Operating Officer
These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.
Includes 68 shares acquired on August 31, 2026, under the Issuer's employee stock purchase plan.
This transaction was executed in multiple trades at prices ranging from $33.015 to $33.900, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby un…
Held by the Fritz Shorter Trust of which the Reporting Person and her spouse are the trustees and beneficiaries.
The shares subject to the option are fully vested.
0 other filings
0 recent txs